Fairview Specialty Pharmacy: Minnesota’s 2027 UHC Exit Guide

The Clock Is Ticking: Fairview Exits UnitedHealthcare Medicare Advantage on January 1, 2027

Starting January 1, 2027, Fairview Health Services, including Fairview Specialty Pharmacy, will be out-of-network for all UnitedHealthcare Medicare Advantage plans. For Minnesota seniors who rely on specialty medications, this change could reshape how they access their prescriptions.

This is not a negotiating tactic. In its official coverage update, Fairview describes the decision as final. The health system says it chose to stop contracting with UnitedHealthcare Medicare Advantage because “ongoing issues such as frequent coverage changes, denials, and payment issues” have made it difficult for patients to get timely, high-quality care. The Star Tribune has reported that up to 125,000 patients across the state could be affected.

The most important window is already approaching. The Medicare Annual Enrollment Period runs from October 15 through December 7, 2026, and that is when affected patients can review and change their coverage before the exit takes effect.

Most news coverage has focused on hospital and clinic access across M Health Fairview. This guide looks at a narrower but more fragile group: patients who depend on specialty medications. It explains what Fairview Specialty Pharmacy does well, where friction tends to appear, and what a practical backup plan looks like.

Why This Matters More for Specialty Pharmacy Patients Than General Care

Switching pharmacies for a routine blood pressure prescription is usually a minor inconvenience. Switching in the middle of therapy for a biologic, an infusion, or a transplant anti-rejection drug is a different matter.

Specialty medications often come with limited distribution networks, strict handling requirements, and close clinical monitoring. When a pharmacy loses in-network status, patients who are already stable on a regimen may face:

• New prior authorizations, even for medications they have taken for years
• New pharmacy network requirements, where the plan steers them to a different specialty pharmacy
• Coverage gaps during the handoff between one pharmacy and another

Patients facing this transition should ask their plan and their care team about continuity-of-care provisions, transition fills, and how long current authorizations remain valid. This guide does not offer legal or insurance advice, but those questions deserve direct answers before January 1.

The rest of this article works as a two-part resource. The first part offers a balanced look at Fairview Specialty Pharmacy’s strengths and weaknesses. The second explains how a compounding pharmacy can serve as a contingency for gaps that no specialty pharmacy can fill.

What Fairview Specialty Pharmacy Does Well

This is not a hit piece. It is a risk map, and any honest risk map begins with what is working.

A 1997 Transplant-Pharmacy Legacy

Fairview Specialty Pharmacy was created in 1997 to help University of Minnesota transplant patients manage the complex medication regimens required after organ transplantation. Since then, it has grown into one of the more advanced transplant specialty pharmacies in the industry.

Today it serves patients with rheumatoid arthritis, Crohn’s disease, multiple sclerosis, cystic fibrosis, hepatitis C, psoriasis, cancer, hemophilia, and solid organ transplants. Many of these therapies require injection, infusion, or special handling.

URAC Accreditation and Rare Disease Center of Excellence

The pharmacy holds URAC’s Specialty Pharmacy Accreditation along with a Rare Disease Pharmacy Center of Excellence Designation. Only a few specialty pharmacies nationwide hold that combined distinction.

It operates from two primary locations:

• 711 Kasota Ave SE, Minneapolis
• 3650 Victoria St N, Shoreview

Patients use separate phone lines depending on their needs: 612-672-5260 for general specialty and rare disease patients, and 612-617-3700 for transplant patients.

Service Promises Worth Noting

Fairview Specialty Pharmacy advertises free nationwide delivery, 24/7 pharmacist availability, live phone answer with no phone tree, and the option to bundle other prescriptions and supplies into a single shipment.

Research supports the value of this integrated model. A 2026 study found that health-system specialty pharmacies like Fairview’s outperform external, non-integrated competitors. Patients served by non-integrated models showed 60% higher odds of medication non-adherence and 40% higher odds of longer turnaround times. In practical terms, integrated pharmacies are linked to meaningfully better adherence and faster fills. That explains why so many Minnesota patients turn to Fairview first, and it also shows what is at stake if they are forced to go elsewhere.

Where the Friction Shows Up: Documented Pain Points

A fair assessment also has to look at what the data and patient reviews actually show.

Prior Authorization Denials Are a National Problem, Not Just Fairview’s

Prior authorization friction affects the entire specialty pharmacy sector:

• National specialty pharmacy PA denial rates run 25% to 40% on first pass.
• According to Surescripts, half of specialty pharmacists report that the average specialty prescription takes at least four days to fill, and waits of 7 to 10 days are not uncommon.
• 40% of specialty pharmacists say they feel “more like an admin than a pharmacist” because of PA burden.

That last figure points to strain across the whole system, and patients feel that strain as delays.

Call-Center Strain and Mixed Patient Reviews

Employee reviews on Indeed describe the specialty pharmacy call center as high-stress. Reviewers say workflow changes were made “with zero input from the employees” and describe a “toxic work environment.” Internal strain of that kind can lead to slower or less personal service for patients.

Patient feedback is mixed. Birdeye shows a 3.6-star rating across 89 reviews. One reviewer said the specialty pharmacy branch on Kasota gave “the distinct impression they work for UCare and not the patient” when it came to approving a costly medication. That reviewer was referring specifically to the specialty pharmacy, not to Fairview’s separate compounding pharmacy branch.

Drug Shortages Compound the Problem

Supply chain pressure adds another layer of risk. ASHP tracked 227 active national drug shortages in Q2 2026, the third consecutive quarterly increase. In addition, 48% of new 2026 shortages involve sole-source products that have no alternate manufacturer.

Even a well-run specialty pharmacy cannot dispense a medication that is not being made. This is one reason compounding matters, and it applies regardless of any insurance dispute.

The Four Scenarios Where Minnesota Patients’ Access Could Break Down

The points above can be organized into a simple framework that patients can use to assess their own risk.

Scenario 1: Your Medicare Advantage Plan Goes Out-of-Network (Jan. 1, 2027)

Patients enrolled in UnitedHealthcare Medicare Advantage plans will lose in-network access to Fairview Specialty Pharmacy when the new year begins.

Action trigger: Review coverage options during the October 15 to December 7, 2026 open enrollment period.

Scenario 2: A Prior Authorization Gets Denied

With first-pass denial rates of 25% to 40%, a denial is a realistic possibility for many specialty patients. Appeals can succeed, but they take time, and patients with active disease often cannot afford to wait.

Scenario 3: The Drug Is on National Shortage or Discontinued

With 227 active shortages and nearly half of new shortages tied to sole-source products, some medications may simply be unavailable. This has nothing to do with insurance or with Fairview’s performance. It is a supply chain reality.

Scenario 4: Service Friction Makes Ongoing Care Difficult

Call-center strain and mixed reviews suggest that some patients will run into service barriers. Others need options that no specialty pharmacy stocks at all, such as flexible dosage forms, flavored preparations, or non-standard strengths for pediatric, transplant, or pain management care.

The Continuity Plan: What to Do When Fairview Can’t Fill the Gap

Once the risks are clear, the next question is what patients can do about them.

Compounding pharmacies are a parallel resource, not a competing one. Most patients will continue to use Fairview or another specialty pharmacy for commercially manufactured biologics and other branded specialty drugs. Compounding addresses specific gaps that commercial products leave open.

What Compounding Pharmacies Do Differently

Compounding pharmacies prepare custom formulations that are not available commercially. These can include different strengths, alternative dosage forms, flavored preparations, or versions free of particular allergens.

Compounding is a small but resilient niche. According to industry measures cited by the Star Tribune, compounding pharmacies account for fewer than 3% of U.S. prescriptions in a roughly $9 billion industry. Fairview’s own pharmacy COO has said, “there’s always going to be the need for it, and there are less and less compounding pharmacies in the marketplace.”

It is important to understand that compounding is not an insurance workaround. It is a separate category of pharmacy service, designed for medication needs that standard pharmacies cannot meet.

Nationwide Compounding Rx: A PCAB-Accredited Option for Minnesota Patients

Nationwide Compounding Rx®, based in Scottsdale, Arizona, offers a structured option for patients and prescribers who need customized formulations:

• PCAB accredited and USP 800 compliant, with 40+ years of combined team experience
• 1 to 2 business day turnaround, with same-day pickup available for some medications
• Nationwide shipping, with availability depending on medication type and state licensing tier (fully licensed, non-sterile only, or pending)
• Independent third-party testing and sourcing of high-grade chemicals from FDA-inspected and cleared vendors
• Secure provider and patient portals for prescription submission, order tracking, and refill management

The pharmacy works with prescribers through its “Connect, Collaborate, Create, Care” partnership model, which positions it as an extension of the care team rather than a transactional dispensary.

Formulation Categories Relevant to Fairview’s Patient Population

Several of Nationwide Compounding Rx’s specialties line up with the needs of Fairview’s specialty patients:

• Bioidentical Hormone Replacement Therapy (BHRT): Customized hormone formulations for menopause and andropause, adjustable at each refill based on lab results. These may suit patients managing chronic hormonal conditions.
• Pain management: Topical creams, gels, and ointments that localize treatment and reduce systemic side effects, including addiction risk. These may be relevant for patients with RA, MS, or post-transplant pain.
• Pediatric formulations: Age- and weight-specific medications in flavored, kid-friendly forms such as liquids, popsicles, and suckers, for younger patients who need non-standard dosing.
• Sports medicine: Recovery- and inflammation-focused formulations that may complement care for chronic inflammatory conditions such as RA or psoriasis.

Formulations can also be prepared without dyes, fillers, preservatives, or common allergens, which matters for medically sensitive patients.

Fairview’s Own Compounding Pharmacy vs. an Independent Alternative

Minnesota patients have more than one compounding option. A fair comparison helps them choose the right fit.

What Fairview Compounding Pharmacy Offers

Fairview Compounding Pharmacy operates separately from Fairview Specialty Pharmacy. It is located at 711C Kasota Ave SE, Minneapolis, with an additional location in Shoreview. It prepares sterile and non-sterile compounds, including low-dose naltrexone, bioidentical hormone replacement, topical pain creams, and allergy immunotherapy serums.

For transparency, a 2018 FDA Form 483 inspection cited sterile-compounding glove-sanitization lapses at the facility. Fairview responded by retraining staff and halting a specific progesterone compound until equipment could be validated. This history is offered as context for patients evaluating quality and safety, not as a criticism.

Why Minnesota Patients May Still Want an Independent, Nationwide Option

• Backup access: If Fairview’s network status, location, or capacity becomes a barrier under the 2027 UHC change, an independent pharmacy offers another route.
• Continuity across systems: Nationwide shipping means a patient’s continuity of care does not depend on one regional health system’s insurance contracts.
• Comparable quality assurance: PCAB accreditation and independent third-party testing give patients a recognized standard to use when comparing alternatives.

Action Steps for Minnesota Patients Before January 1, 2027

1. Review Medicare Advantage plan options during the October 15 to December 7, 2026 enrollment window, paying close attention to specialty pharmacy networks.
2. Contact Fairview Specialty Pharmacy directly (612-672-5260 for specialty and rare disease, 612-617-3700 for transplant) to confirm how a specific regimen will be affected.
3. Ask about continuation-of-care provisions, transition fills, and whether existing prior authorizations will carry over.
4. Identify backup options for any medication at risk of PA denial, shortage, or network loss, and discuss them with the prescribing provider.
5. Keep a compounding pharmacy contact on file as a contingency, not a replacement, for formulations that commercial pharmacies cannot supply.

Conclusion

Fairview Specialty Pharmacy remains a credible, accredited resource with real strengths. Its 1997 transplant legacy, URAC accreditation, and Rare Disease Pharmacy Center of Excellence designation are not in question.

The deadline is firm, however. The January 1, 2027 exit from UnitedHealthcare Medicare Advantage cannot be pushed back. Combined with national prior authorization denial rates and a growing number of drug shortages, it leaves Minnesota specialty patients facing several realistic points of disruption. Setting up a compounding pharmacy contingency is simply prudent planning, and it does not signal any distrust in Fairview.

Protect Your Medication Continuity With Nationwide Compounding Rx

The best time to establish a relationship with a compounding pharmacy is before a disruption, not in the middle of one. Nationwide Compounding Rx makes the first step simple through its secure Provider Portal and Patient Portal, which allow prescribers and patients to submit prescriptions, track orders, and manage refills.

With PCAB accreditation, nationwide shipping, and a 1 to 2 business day turnaround, Nationwide Compounding Rx gives Minnesota patients and providers a dependable contingency ahead of the 2027 transition.

Contact Nationwide Compounding Rx®:

• Phone: (480) 499-8379
• Website: nationwidecompounding.com
• Hours: Monday through Friday, 7:00 AM to 3:30 PM